Preparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin delivery

European Journal of Pharmaceutical Sciences

Volumn 34, Issue 2-3, 2008, Pages 85-93

  Gao, Jieming ^a,c   Ming, Jing ^b   He, Bin ^c   Fan, Yujiang ^c   Gu, Zhongwei ^c   Zhang, Xingdong ^c  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

^b Second People's Hospital of Sichuan   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

9 Nitro 20(S) camptothecin; Controlled release; d,l Lactide; Micelles; Stability; Trimethylene carbonate

Indexed keywords

9 NITRO 20 CAMPTOTHECIN; BUFFER; CAMPTOTHECIN; COPOLYMER; LACTONE; POLYMER;

ARTICLE; CONTACT ANGLE; CONTROLLED RELEASE FORMULATION; CRITICAL MICELLE CONCENTRATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; ENCAPSULATION; HYDROPHOBICITY; IN VITRO STUDY; MICELLE; MOLECULAR WEIGHT; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; DIOXANES; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; ELECTROCHEMISTRY; EXCIPIENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERS; SOLUBILITY; THERMODYNAMICS;

EID: 44349172367     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.01.016     Document Type: Article

References (40)

1. Allen C., Maysinger D., and Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloid Surf. B 16 (1999) 3-27
2. Bazile D., Prud'homme C., Bassoullet M.T., Marlard M., Spenlehauer G., Veillard M., and Stealth M.E. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 84 (1995) 493-498
3. Cai J., and Zhu K.J. Preparation, characterization and biodegradable characteristics of poly(d,l-lactide-co-1,3 trimethylene carbonate). Polym. Int. 42 (1997) 373-379
4. Chen J., Ping Q.N., Guo J.X., and Ding M.G. Effect of liposomes encapsulation on equilibrium between lactone and carboxylate forms of 9-nitro camptothecin in vitro. J. Chin. Pharm. Univ. 36 (2005) 316-320
5. Cortesi R., and Esposito E. Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion. Int. J. Pharm. 159 (1997) 95-103
6. Daoud M., and Cotton J.P. Star-shaped polymers: a model for the conformation and its concentration dependence. J. Phys. (Fr.) 43 (1982) 531-538
7. Dong Y.C., and Feng S.S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25 (2004) 2843-2849
8. Erichson-miller C.L., May R.D., Tomaszewski J., Osborn B., Murphy M.J., Page J.G., and Parchment R.E. Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro. Cancer Chemother. Pharmacol. 39 (1997) 467-472
9. Ertl B., Platzer P., Wirth M., and Gabor F. Poly(d,l-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin. J. Control. Release 61 (1999) 305-317
10. Garcia-Carbonero R., and Supko J.G. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin. Cancer Res. 8 (2002) 641-661
11. Giovanella B.C., Hinz H.R., Kozielski A.J., Stehlin J.S., Silber R., and Potmesil M. Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20(S)-camptothecin. Cancer Res. 51 (1991) 3052-3055
12. Giovanella B.C., Stehlin J.S., Hinz H.R., Kozielski A.J., Harris N.J., and Vardeman D.M. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan). Int. J. Oncol. 20 (2002) 81-88
13. Govender T., Stolnik S., Garnett M.C., Illum L., and Davis S.S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release 99 (1999) 171-185
14. Govindachari T.R., and Visnawathan N. Alkaloids of Mappia foetida. Phytochemistry 11 (1972) 3529-3531
15. Gref R., Minamitake Y., Peracchia M.T., Trebetskoy V.S., Torchilin V.P., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
16. Haglof K.J., Popa E., and Hochster H.S. Recent developments in the clinical activity of topoisomerase-1 inhibitors. Update Cancer Therap. 1 (2006) 117-145
17. Kim S.Y., Shin I.L.G., and Lee Y.M. Methoxy poly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours. J. Control. Release 51 (1998) 13-22
18. Kumar N., Ravikumar M.N.V., and Domb A.J. Biodegradable block copolymers. Adv. Drug Deliv. Rev. 53 (2001) 23-44
19. Lavasanifar A., Samuel J., and Kwon G.S. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate l-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. J. Control. Release 77 (2001) 155-160
20. Lee J., Cho E.C., and Cho K. Incorporation and release behavior of hydrophobic drug in functionalized poly(d,l-lactide)-block-poly(ethylene oxide) micelles. J. Control. Release 94 (2004) 323-335
21. Lee S.C., Kim C., Kwon I.C., Chung H., and Jeong S.Y. Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) copolymer as a carrier for paclitaxel. J. Control. Release 89 (2003) 437-446
22. Lele B.S., and Leroux J.C. Synthesis and micellar characterization of novel amphiphilic A-B-A triblock copolymers of N-(2-hydroxypropyl) methacrylamide or N-vinyl-2-pyrrolidone with poly(ε-caprolactone). Macromolecules 35 (2002) 6714-6723
23. Lucke A., Teβmar J., Schnell E., Schmeer G., and Gopferich A. Biodegradable poly(d,l-lactic aicd)-poly(ethylene glycol)-monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterials. Biomaterials 21 (2000) 2361-2370
24. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41 (2000) 189-207
25. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2002) 271-284
26. Mao J., Guo Y., Xia Y., and Gu Z. Synthesis and characterization of poly(d,l-lactide-co-cyclic carbonate) with hydroxyl pendant functional groups. Acta Polym. Sin. 9 (2006) 1121-1124
27. Nah J.W., Jeong Y.I., and Cho C.S. Clonazepam release from core-shell type nanoparticles composed of poly(γ-benzyl l-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part. J. Polym. Sci. B: Polym. Phys. 36 (1998) 415-423
28. Opanasopit P., Ngawhirunpat T., Rojanarata T., Choochottiros C., and Chirachanchai S. Camptothecin-incorporating N-phthaloylchitosan-g-mPEG self-assembly micellar system: effect of degree of deacetylation. Colloid Surf. B: Biointerfaces 60 (2007) 117-124
29. Ould-Ouali L., Arien A., Rosenblatt J., Nathan A., Twaddle P., Matalenas T., Borgia M., Arnold S., Leroy D., Dinguizli M., Rouxhet L., Brewster M., and Préat V. Biodegradable self-assembling PEG-copolymers as vehicle for poorly water-soluble drugs. Pharm. Res. 21 (2004) 1581-1590
30. Redinbo M.R., Stewart L., Kuhn P., Champoux J.J., and Hol W.G.J. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279 (1998) 1504-1513
31. Rokicki G. Aliphatic cyclic carbonates and spiroorthocarbonates as monomers. Prog. Polym. Sci. 25 (2000) 259-342
32. Sezgin Z., Yuksel N., and Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur. J. Pharm. Biopharm. 64 (2006) 261-268
33. Shi I.G., Kim S.Y., Lee Y.M., Sung Y.K., Akaike T., and Cho C.S. Methoxy poly(ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. J. Control. Release 51 (1998) 1-11
34. Verschraegen C.F., Natelson E.A., Giovanella B.C., Kavanagh J.J., Kudelka A.P., Freedman R.S., Edwards C.L., Ende K., and Stehlin J.S. A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor. Anticancer Drugs 9 (1998) 36-44
35. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., McPhail A.T., and Sim G.A. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J. Am. Chem. Soc. 88 (1966) 3888-3890
36. Yamamoto Y., Nagasaki Y., Kato Y., Sugiyama Y., and Kataoka K. Long-circulating poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles with modulated surface charge. J. Control. Release 77 (2001) 27-38
37. Younes H., Nataf P.R., Cohn D., Appelbaum Y.J., Pizov G., and Uretzky G. Biodegradable PELA block copolymers: in vitro degradation and tissue reaction. Biomater. Artif. Cells Artif. Organs 16 (1988) 705-719
38. Zhang Y., and Zhuo R.X. Synthesis and drug release behavior of poly(trimethylene carbonate)-poly(ethylene glycol)-poly(trimethylene carbonate) nanoparticles. Biomaterials 26 (2005) 2089-2094
39. Zhang Y., and Zhuo R.X. Synthesis, characterization, and in vitro 5-fu release behavior of poly(2,2-dimethyltrimethylene carbonate)-poly(ethylene glycol)-poly(2,2-dimethyltrimethylene carbonate) nanoparticles. J. Biomed. Mater. Res. 76A (2005) 674-680
40. Zhang Z., Grijpma D.W., and Feijen J. Thermo-sensitive transition of monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) films to micellar-like nanoparticles. J. Control. Release 112 (2006) 57-63